Study: Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease.
Phase II
· Site: 710 (USA) (Dr. Silva)
· consented 2013-11-17
Adverse events
5
Serious AEs
0
Open data queries
0
Luna dropout signal
–
Adverse events
mild
assessed
2026-08-18
Mild AGITATION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-01-12 (study day 57.0); relationship: REMOTE
mild
assessed
2026-08-18
Mild APPLICATION SITE DERMATITIS — outcome: RECOVERED/RESOLVED; onset 2013-12-12 (study day 26.0); relationship: POSSIBLE
severe
assessed
2026-08-18
Severe ARTHRITIS — outcome: NOT RECOVERED/NOT RESOLVED; onset 1977; relationship: NONE
moderate
assessed
2026-08-18
Moderate ARTHRITIS — outcome: NOT RECOVERED/NOT RESOLVED; onset 1977; relationship: NONE
mild
assessed
2026-08-18
Mild SKIN IRRITATION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-12-27 (study day 41.0); relationship: POSSIBLE
Data queries
No data queries.
☾ Luna engagement
This participant doesn't use Luna.